{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:55:42Z","timestamp":1767851742597,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>[<jats:sup>18<\/jats:sup>F]AlF-NOTA-FAPI-04 demonstrates significant physiological uptake in the gallbladder and biliary tract system, representing a limitation of this positron emission tomography (PET) tracer. The aim of this study was to evaluate the impact of milk consumed prior to a PET\/CT scan on [<jats:sup>18<\/jats:sup>F]AlF-NOTA-FAPI-04 uptake in normal abdominal organs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A total of 86 patients who underwent [<jats:sup>18<\/jats:sup>F]AlF-NOTA-FAPI-04 PET\/CT imaging took part in this single-center retrospective clinical study at the Hunan Cancer Hospital between December 2020 and August 2021. Patients were divided into two groups according to their pre-PET scan diet: treated group, who consumed 250\u2009mL of milk 10\u2009\u00b1\u20095\u2009min after the tracer injection, while the control group was permitted no food intake subsequent to the radiotracer administration. The mean standardized uptake value (SUV<jats:sub>mean<\/jats:sub>) of gallbladder, liver, small intestine and pancreas were measured in <jats:sup>18<\/jats:sup>F-FAPI and <jats:sup>18<\/jats:sup>F-FDG PET\/CT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a statistically significant difference in the <jats:sup>18<\/jats:sup>F-FAPI uptake in the gallbladder between the treated group and the control group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). The average SUV<jats:sub>mean<\/jats:sub> in the treated group was 2.19\u2009\u00b1\u20092.01, which was significantly lower than the average SUV<jats:sub>mean<\/jats:sub> of 10.04\u2009\u00b1\u20099.66 in the control group. In the subgroup analysis of patients who underwent paired [<jats:sup>18<\/jats:sup>F]FDG and [<jats:sup>18<\/jats:sup>F]FAPI PET\/CT scans, the <jats:sup>18<\/jats:sup>F-FAPI uptake of liver and small intestine was significantly lower than the <jats:sup>18<\/jats:sup>F-FDG uptake in both the treated group and the control group (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests that milk consumption decreases physiological <jats:sup>18<\/jats:sup>F-FAPI uptake in the gallbladder, potentially enhancing the diagnostic accuracy for gallbladder cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1464779","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:44:21Z","timestamp":1730954661000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of fat intake on [18F]AlF-NOTA-FAPI-04 uptake in normal abdominal organs"],"prefix":"10.3389","volume":"11","author":[{"given":"Jiashun","family":"Dai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengzhi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1158\/1535-7163.Mct-11-0340","article-title":"Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy","volume":"11","author":"Brennen","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4161\/cbt.13.3.18696","article-title":"Fibroblast activation protein: a potential therapeutic target in cancer","volume":"13","author":"Liu","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1593\/neo.121850","article-title":"Targeting inhibition of fibroblast activation protein-\u03b1 and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments","volume":"15","author":"Christiansen","year":"2013","journal-title":"Neoplasia"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of Quinoline-based Theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of Cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J Nucl Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2967\/jnumed.119.239731","article-title":"Design and development of (99m)Tc-labeled FAPI tracers for SPECT imaging and (188)re therapy","volume":"61","author":"Lindner","year":"2020","journal-title":"J Nucl Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2967\/jnumed.119.233122","article-title":"Theranostics targeting fibroblast activation protein in the tumor stroma: (64)cu- and (225)ac-labeled FAPI-04 in pancreatic Cancer xenograft mouse models","volume":"61","author":"Watabe","year":"2020","journal-title":"J Nucl Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s00259-020-05095-0","article-title":"Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [(68)Ga]Ga-FAPI-04 PET\/CT versus MRI and [(18)F]-FDG PET\/CT","volume":"48","author":"Guo","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","article-title":"Comparison of (68)Ga-FAPI and (18)F-FDG uptake in gastric, duodenal, and colorectal cancers","volume":"298","author":"Pang","year":"2021","journal-title":"Radiology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1007\/s00259-021-05255-w","article-title":"A head-to-head comparison of (68)Ga-DOTA-FAPI-04 and (18)F-FDG PET\/MR in patients with nasopharyngeal carcinoma: a prospective study","volume":"48","author":"Qin","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00259-022-05729-5","article-title":"Comparison of the diagnostic efficacy of (68) Ga-FAPI-04 PET\/MR and (18)F-FDG PET\/CT in patients with pancreatic cancer","volume":"49","author":"Zhang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1053\/snuc.2002.29270","article-title":"Initial and subsequent approach for the synthesis of 18FDG","volume":"32","author":"Fowler","year":"2002","journal-title":"Semin Nucl Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s00259-020-04961-1","article-title":"The battle on time, money and precision: Da[(18)F] id vs. [(68)Ga]liath","volume":"47","author":"Sahnoun","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.2967\/jnumed.120.242958","article-title":"Targeting fibroblast activation protein: Radiosynthesis and preclinical evaluation of an (18)F-labeled FAP inhibitor","volume":"61","author":"Toms","year":"2020","journal-title":"J Nucl Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2967\/jnumed.120.245084","article-title":"FAPI-74 PET\/CT using either (18)F-AlF or cold-kit (68)Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung Cancer patients","volume":"62","author":"Giesel","year":"2021","journal-title":"J Nucl Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"649148","DOI":"10.3389\/fonc.2021.649148","article-title":"FAPI-04 PET\/CT using [(18)F]AlF labeling strategy: automatic synthesis, quality control, and in vivo assessment in patient","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41181-021-00144-x","article-title":"(18)F-labeled tracers targeting fibroblast activation protein","volume":"6","author":"Lindner","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","article-title":"Clinical translational evaluation of Al(18)F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.apsb.2021.09.032","article-title":"Preclinical evaluation and pilot clinical study of [(18)F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts","volume":"12","author":"Hu","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s00259-022-05758-0","article-title":"[(18)F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET\/CT imaging of various cancers","volume":"49","author":"Wei","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2967\/jnumed.123.266283","article-title":"(18)F-FAPI-04 outperforms (18)F-FDG PET\/CT in clinical assessments of patients with pancreatic adenocarcinoma","volume":"65","author":"Li","year":"2024","journal-title":"J Nucl Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnume.2022.927843","article-title":"Comparison of physiological uptake of normal tissues in patients with cancer using 18F-FAPI-04 and 18F-FAPI-42 PET\/CT","volume":"2","author":"Mu","year":"2022","journal-title":"Front Nucl Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jmri.10340","article-title":"Biliary motor function in gallstone patients evaluated by fatty-meal MR cholangiography","volume":"18","author":"Inoue","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5830\/cvja-2015-033","article-title":"Efficacy of full-fat milk and diluted lemon juice in reducing infra-cardiac activity of (99m)Tc sestamibi during myocardial perfusion imaging","volume":"26","author":"Purbhoo","year":"2015","journal-title":"Cardiovasc J Afr"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/01.mnm.0000237989.60196.71","article-title":"Efficacy of milk versus water to reduce interfering infra-cardiac activity in 99mTc-sestamibi myocardial perfusion scintigraphy","volume":"27","author":"Hofman","year":"2006","journal-title":"Nucl Med Commun"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3390\/cancers15041193","article-title":"The superiority of fibroblast activation protein inhibitor (FAPI) PET\/CT versus FDG PET\/CT in the diagnosis of various malignancies","volume":"15","author":"Dong","year":"2023","journal-title":"Cancers (Basel)."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00330-022-09251-y","article-title":"Usefulness of [(68)Ga]FAPI-04 and [(18)F]FDG PET\/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study","volume":"33","author":"Li","year":"2023","journal-title":"Eur Radiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/mnm.0000000000001563","article-title":"Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET\/CT imaging","volume":"43","author":"Kou","year":"2022","journal-title":"Nucl Med Commun"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"100357","DOI":"10.1016\/j.jhepr.2021.100357","article-title":"Hepatic bile acid transport increases in the postprandial state: a functional (11)C-CSar PET\/CT study in healthy humans","volume":"3","author":"Heraghty","year":"2021","journal-title":"JHEP Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e37777","DOI":"10.7759\/cureus.37777","article-title":"Prevalence of symptomatic gallbladder disease after bariatric surgery: a literature review","volume":"15","author":"Alsallamin","year":"2023","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","article-title":"Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients","volume":"48","author":"Giesel","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref35","first-page":"27","article-title":"Release of cholecystokinin and gallbladder contraction before and after gastrectomy","volume":"205","author":"Inoue","year":"1987","journal-title":"Ann Surg"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/bjc.1992.77","article-title":"Enhancing effect of partial gastrectomy on pancreatic carcinogenesis","volume":"65","author":"Watanapa","year":"1992","journal-title":"Br J Cancer"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3904\/kjim.2000.15.1.19","article-title":"Changes in gallbladder motility in gastrectomized patients","volume":"15","author":"Hahm","year":"2000","journal-title":"Korean J Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/jcp.19.4.389","article-title":"Prediction of lean body mass from height and weight","volume":"19","author":"Hume","year":"1966","journal-title":"J Clin Pathol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1464779\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T04:44:27Z","timestamp":1730954667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1464779\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":38,"alternative-id":["10.3389\/fmed.2024.1464779"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1464779","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"article-number":"1464779"}}